Karyopharm Therapeutics (KPTI) Other Non-Current Liabilities (2014 - 2026)
Karyopharm Therapeutics (KPTI) reported Other Non-Current Liabilities of $72.34 million for Q2 2026, down 1.6% from $73.5 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Dating back to Q1 2014, Karyopharm Therapeutics' Other Non-Current Liabilities record includes 47 quarters.
- Other Non-Current Liabilities has declined for four consecutive years, with a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $73.5 million in FY2024 (-44.5%), $132.48 million in FY2023 (-0.2%), $132.72 million in FY2022 (-0.2%) and $133 million in FY2021 (+82.0%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $72.34 million in Q4 2025 and a high of $133 million in Q3 2022.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q1 2022 (growth of 82.0%); the low point was Q2 2024 (a decline of 44.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Karyopharm Therapeutics | 12.16 Mn | -214.27 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.67 Mn |
| Dec 31, 2025 | 83.43 Mn |
| Sep 30, 2025 | 87.62 Mn |
| Jun 30, 2025 | 81.76 Mn |
| Mar 31, 2025 | 78.65 Mn |
| Dec 31, 2024 | 75.93 Mn |
| Sep 30, 2024 | 79.68 Mn |
| Jun 30, 2024 | 77.78 Mn |
| Mar 31, 2024 | 135.06 Mn |
| Dec 31, 2023 | 133.46 Mn |
| Sep 30, 2023 | 133.91 Mn |
| Jun 30, 2023 | 135.15 Mn |
| Mar 31, 2023 | 133.80 Mn |
| Dec 31, 2022 | 132.72 Mn |
| Sep 30, 2022 | 133.00 Mn |
| Jun 30, 2022 | 133.00 Mn |
| Mar 31, 2022 | 133.00 Mn |
| Dec 31, 2021 | 133.00 Mn |
| Sep 30, 2021 | 132.48 Mn |
| Jun 30, 2021 | 132.48 Mn |
API Access
Karyopharm Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();